Table 1. Patient characteristics... | American Society of Hematology

Table 1.

Patient characteristics

Clinical feature	No. patients	All patients evaluable for characteristic	%
Stage III/IV	37	40	92.5
2 or more extranodal sites	24	34	70.6
WHO performance status of 2 or more	6	30	20.0
Leukemic	24	38	63.2
LDH level elevated	10	31	32.3
t(11;14)-positive	53	53	100.0
CD5-positive	41	42	97.6
CD19/CD20-positive	42	42	100.0
CD23-negative	39	42	92.9

Clinical feature	No. patients	All patients evaluable for characteristic	%
Stage III/IV	37	40	92.5
2 or more extranodal sites	24	34	70.6
WHO performance status of 2 or more	6	30	20.0
Leukemic	24	38	63.2
LDH level elevated	10	31	32.3
t(11;14)-positive	53	53	100.0
CD5-positive	41	42	97.6
CD19/CD20-positive	42	42	100.0
CD23-negative	39	42	92.9

WHO indicates World Health Organization.